Central endoscopy reads in inflammatory bowel disease clinical trials: The role of the imaging core lab

Clinical trials in inflammatory bowel disease (IBD) are evolving at a rapid pace by employing central reading for endoscopic mucosal assessment in a field that was, historically, largely based on assessments by local physicians. This transition from local to central reading carries with it numerous technical, operational, and scientific challenges, many of which can be resolved by imaging core laboratories (ICLs), a concept that has a longer history in clinical trials in a number of diseases outside the realm of gastroenterology. For IBD trials, ICLs have the dual goals of providing objective, consistent assessments of endoscopic findings using central-reading paradigms whilst providing important expertise with regard to operational issues and regulatory expectations. This review focuses on current approaches to using ICLs for central endoscopic reading in IBD trials.

• Publication year

  2014

• Venue

  Gastroenterology Report

• Publication date

  2014-07-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/gastro/gou033PMID 24994835PMCID 4124272
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

  2016cited by this paper
• Clevidipine Rapidly and Safely Reduces Blood Pressure in Acute Intracerebral Hemorrhage: The ACCELERATE Trial

  2013cited by this paper
• Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study.

  2013cited by this paper
• The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis.

  2013cited by this paper
• Rate of adjudication of radiological progression in rheumatoid arthritis randomized controlled trials depending on preset limits of agreement: a pooled analysis from 15 randomized trials.

  2013cited by this paper
• Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

  2012cited by this paper
• Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks

  2012cited by this paper
• Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial.

  2012cited by this paper
• Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study.

  2011cited by this paper
• Translational Gastroenterology

  2011cited by this paper
• Guidance for Industry Standards for Clinical Trial Imaging Endpoints

  2011cited by this paper
• Blinded independent central review of the progression-free survival endpoint.

  2010cited by this paper
• Validation of novel imaging methodologies for use as cancer clinical trial end-points.

  2009cited by this paper
• New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

  2009cited by this paper
• Lessons learned from independent central review.

  2009cited by this paper
• Recommendations for the assessment of progression in randomised cancer treatment trials.

  2009cited by this paper
• Blinded independent central review of progression-free survival in phase III clinical trials: important design element or unnecessary expense?

  2008cited by this paper
• Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation

  2007cited by this paper
• A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis.

  2007cited by this paper
• Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

  2005cited by this paper
• Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD.

  2004cited by this paper
• Phase II trial of bortezomib for patients with advanced renal cell carcinoma.

  2004cited by this paper
• Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).

  1989cited by this paper
• Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.

  1987cited by this paper
• Variation Between Observers in Describing Mucosal Appearances in Proctocolitis*

  1964cited by this paper
• FINAL REPORT ON A THERAPEUTIC TRIAL

  1955cited by this paper
• Cortisone in Ulcerative Colitis

  1954cited by this paper

• Considerations for Colorectal Neoplasia Detection in Inflammatory Bowel Disease Clinical Trials

  2023cites this paper
• Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program

  2022cites this paper
• Phase 1, 2 and 3 trials in inflammatory bowel diseases: a practical guide for the non-specialist.

  2020cites this paper
• Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments

  2020cites this paper
• Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial.

  2017cites this paper
• The 2 + 1 paradigm: an efficient algorithm for central reading of Mayo endoscopic subscores in global multicenter phase 3 ulcerative colitis clinical trials

  2015cites this paper
• Computer vision and augmented reality in gastrointestinal endoscopy

  2015cites this paper
• Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials

  2015cites this paper
• Voting for Image Scoring and Assessment (VISA) - theory and application of a 2 + 1 reader algorithm to improve accuracy of imaging endpoints in clinical trials

  2015cites this paper
• Knockout of MIMP protein in lactobacillus plantarum lost its regulation of intestinal permeability on NCM460 epithelial cells through the zonulin pathway

  2014cites this paper